NCT07643090

Brief Summary

This study develops an end-to-end Vision Transformer (ViT)-based artificial intelligence system for ultrasound-based diagnosis of placenta accreta spectrum (PAS), aiming to improve the accuracy and efficiency of prenatal screening using standardized ultrasound video inputs.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
561

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Sep 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Sep 2025Dec 2027

Study Start

First participant enrolled

September 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

2 years

First QC Date

June 2, 2026

Last Update Submit

June 8, 2026

Conditions

Keywords

Placenta Accreta SpectrumUltrasonographyArtificial IntelligencePrenatal DiagnosisVision Transformer

Outcome Measures

Primary Outcomes (1)

  • Diagnostic performance of the end-to-end Vision Transformer (ViT)-based ultrasound AI model for placenta accreta spectrum (PAS)

    Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic curve (AUC) of the model.

    At delivery (following confirmation of PAS status by surgical and/or pathological findings)

Secondary Outcomes (3)

  • Clinical Feasibility of the Standardized Ultrasound Video Recording Method

    At enrollment during the ultrasound examination

  • Consistency and Efficiency Between the AI Model and Physician Diagnosis

    At enrollment during the ultrasound examination

  • Safety of the AI Model

    At delivery, when PAS status and maternal outcomes are assessed

Interventions

An end-to-end ultrasound AI model based on the Vision Transformer (ViT) architecture was developed for the diagnosis of placenta accreta spectrum (PAS) using standardized ultrasound video inputs. Ultrasound Video Acquisition Protocol: With the patient in the supine position, the operator scanned the lower abdomen using a conventional grayscale probe. Video recording was performed in gray-scale mode for approximately 20-30 seconds, ensuring that the entire scanning region from the lower uterine segment to the uterine fundus was comprehensively captured.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women aged 18-45 years; Gestational age between 24 and 34 weeks; Pregnant women with a history of placenta previa or with an anterior placenta.

You may qualify if:

  • Pregnant women aged between 18 and 45 years;
  • Gestational age between 24 and 34 weeks;
  • Pregnant women with a history of placenta previa;
  • Pregnant women with an anterior placenta;
  • Willingness to participate in the study and provision of written informed consent.

You may not qualify if:

  • Failure to provide written informed consent;
  • Presence of severe complications that precluded continuation of pregnancy;
  • Inability to comply with study procedures for other reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Affiliated Hospital, Guangzhou Medical University

Guangzhou, Guangdong, 510150, China

RECRUITING

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Central Study Contacts

Fang He, M.D, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief Physician/Professor of the Obstetrics Department

Study Record Dates

First Submitted

June 2, 2026

First Posted

June 11, 2026

Study Start

September 1, 2025

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

June 11, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations